What Researchers Did
Researchers retrospectively analyzed the records of 53 severe burn patients from a mass casualty disaster in Taiwan, comparing outcomes between those who received adjunctive hyperbaric oxygen therapy (HBOT) and those who received routine burn care.
What They Found
All 53 patients, with a mean age of 22.4 years and mean total body surface area of 43%, survived and were discharged without limb amputation or permanent disability. Serum procalcitonin levels, a sepsis biomarker, returned to normal significantly faster (p=0.007) in the 38 patients who received adjunctive hyperbaric oxygen therapy compared to the 15 patients who received routine burn therapy.
What This Means for Canadian Patients
For Canadian patients with severe burns, adjunctive hyperbaric oxygen therapy could potentially accelerate the resolution of sepsis biomarkers, suggesting a benefit in managing infection risk. This may contribute to improved recovery trajectories, although further research is needed to confirm broader clinical benefits.
Canadian Relevance
This study was conducted in Taiwan following a specific mass casualty event and has no direct Canadian connection.
Study Limitations
This was a retrospective, single-center study with a relatively small sample size, limiting the generalizability of its findings.